Bio-Sourcing

Bio-Sourcing has developed a breakthrough platform for the production of biotherapeutics. Our platform is 5 to 10 times less expensive than current platforms, the initial investment is much lower and the carbon footprint is extremely low. 

On the other hand, the Bio-Sourcing platform is extremely volatile. We are working on the development of human monoclonal antibodies and bio-betters. Our platform is also suitable for the production of polyclonal antibodies, IgA mAb complexes, and the use of exosomes naturally present would enable the development of oral presentations. After the development and industrialization of products for animal health and the improvement of the legacy technology that enabled the development and registration of products in the US and Europe, Bio-Sourcing is now turning to human health. 

We are actively seeking partners interested in the undeniable benefits of our technology for the production of their biologics candidates or to establish manufacturing facilities in low and middle income countries for regional supply and/or pandemic preparedness.